1. P747 A sharp increase of using biologics for IBD in Israel: a population- based report from the epiIIRN database. (25th January 2019) Authors: Chowers, Y; Asayag, N; Dan, N; Focht, G; Balicer, R; Zittan, E; Matz, E; Brufman, I; Feldman, B; Cahan, A; Lederman, N; Dotan, I; Israeli, E; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DOP89 Final growth in paediatric Crohn's disease is impaired also in the era of biologics: a population-based analysis from the epiIIRN administrative cohort. (25th January 2019) Authors: Assa, A; Cohen, S; Asayag, N; Dan, N; Focht, G; Ledder, O; Lederman, N; Matz, E; Cahan, A; Balicer, R; Feldman, B; Brufman, I; Turner, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗